Patent · US Active

Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta

US8716220B2 · kind B2 · utility

4Cited by
54References
4Claims
0Family size

Inventors

Key dates

Filing dateNov 4, 2009
Grant dateMay 6, 2014
Priority date
Expiry dateDec 1, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2828
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compositions containing a leptin product and methods of clinical therapy and diagnostic methods for progressive cognitive disorders. According to one aspect, the described invention provides a method for treating a progressive cognitive disorder. According to another aspect, the described invention provides a method for improving resilience of cognitive function in a subject in need thereof. According to another aspect, the described invention provides a method for identifying an effective therapeutic agent for treating a progressive cognitive dysfunction disease or disorder that results from at least one of accumulation of Aβ, hyperphosphorylation of tau, or accumulation of neurofibrillary tangles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.